We propose to continue our SCOR on rheumatoid arthritis (RA) to investigate the pathogenetic mechanisms of RA. The current proposal has been designed as a multipronged, in-depth investigation of RA with special emphasis on collagen autoimmunity and the mechanisms of joint destruction and repair. Specifically, efforts will be directed at the following issues: (i) elucidation of the molecular interactions among the type II collagen epitope(s), the Ia molecule and the T cell receptor (TcR) that are involved in the development of autoimmune arthritis and tolerance in mice; (ii) examination of clonality of the activated T cell repertoire present in the rheumatoid synovium; (iii) the mechanisms of signal transduction via cytokine-mediated arachidonic acid metabolism in synovial fibroblasts and the role of these metabolites in the regulation of collagenase and tissue inhibitor of metalloproteases; (iv) in-depth studies of structure/function relationship of three metalloproteases (collagenase, gelatinase, and stromelysin) which may be critically involved in joint destruction; and (v) detailed studies of the mechanisms involved in regulation of collagen gene expression in fibroblasts and in transgenic mice. Supporting these projects will be two core facilities (Molecular Resources and Administrative) which are designed to provide the necessary samples, materials, synthetic oligonucleotides and peptides, the state-of-the-art instrumentation and technical and professional expertise of the highest caliber to the participating projects in the most cost-effective manner. Thus, the approaches will be both clinical and fundamental, and will encompass the disciplines of molecular immunology, biochemistry, cell biology, and molecular biology, in addition to rheumatology. The research described in this proposal represents a natural extension of the fundamental observations made during the present grant period and will be possible only through the multidisciplinary and synergistic cooperation that has developed among the investigators in this SCOR. The physical resources and the intellectual environment of the Connective Tissue Research Laboratories of the University of Tennessee, Memphis, are uniquely favorable for optimal performance of the clinical, animal and bench research necessary for the successful execution of the SCOR projects. Given the outstanding track record of collaboration by the participating investigators, there is every reason to expect a very successful SCOR that will maintain the conducive environment in which rapid progress will continue in research dealing with the pathogenesis of RA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
5P50AR039166-10
Application #
2079430
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1987-09-30
Project End
1999-08-31
Budget Start
1996-09-01
Budget End
1999-08-31
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Qian, Zhaohui; Latham, Kary A; Whittington, Karen B et al. (2013) Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis. J Immunol 190:5382-91
Qian, Zhaohui; Latham, Kary A; Whittington, Karen B et al. (2010) An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis. J Immunol 185:110-8
Tang, Bo; Zhou, Jing; Park, Jeoung-Eun et al. (2009) T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk. Clin Immunol 133:145-53
Myers, Linda K; Tang, Bo; Rosioniec, Edward F et al. (2007) An altered peptide ligand of type II collagen suppresses autoimmune arthritis. Crit Rev Immunol 27:345-56
Ye, X J; Tang, B; Ma, Z et al. (2007) The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances. Clin Exp Immunol 149:553-60
Rosloniec, Edward F; Brandstetter, Tilmann; Leyer, Sigmar et al. (2006) Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models. J Autoimmun 27:182-95
Ahn, Jae I; Erdin, Robert A; Smith, Richard et al. (2006) Chondrocyte injection in distraction epiphysiolysis (rabbit model). J Orthop Res 24:355-65
Rosloniec, Edward F; Ivey 3rd, Robert A; Whittington, Karen B et al. (2006) Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen. J Immunol 177:3884-92
Sakurai, Yoshihiko; Tang, Bo; Rosloniec, Edward F et al. (2006) Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar. Immunology 117:136-42
Sakurai, Yoshihiko; Brand, David D; Tang, Bo et al. (2006) Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. Arthritis Res Ther 8:R150

Showing the most recent 10 out of 122 publications